SHP-2, a SRC homology 2 domain-containing protein tyrosine phosphatase, mediates activation of Ras and mitogen-activated protein kinase by various mitogens and cell adhesion. Inhibition of endogenous SHP-2 by overexpression of a catalytically inactive (dominant negative) mutant in Chinese hamster ovary cells or Rat-1 ®broblasts has now been shown to induce a marked change in cell morphology (from elongated to less polarized) that is accompanied by substantial increases in the numbers of actin stress ®bers and focal adhesion contacts. Overexpression of the SHP-2 mutant also increased the strength of cell-substratum adhesion and resulted in hyperphosphorylation of SHPS-1, a substrate of SHP-2 that contributes to cell adhesioninduced signaling. Inhibition of SHP-2 also markedly increased the rate of cell attachment to and cell spreading on extracellular matrix proteins such as ®bronectin and vitronectin, eects that were accompanied by enhancement of adhesion-induced tyrosine phosphorylation of paxillin and p130Cas. In addition, cell migration mediated by ®bronectin or vitronectin, but not that induced by insulin, was impaired by overexpression of the SHP-2 mutant. These results suggest that SHP-2 plays an important role in the control of cell shape by contributing to cytoskeletal organization, and that it is an important regulator of integrin-mediated cell adhesion, spreading, and migration as well as of tyrosine phosphorylation of focal adhesion contact-associated proteins. Oncogene (2000) 19, 75 ± 84.
Introduction
SHP-2 is a non-transmembrane-type protein tyrosine phosphatase (PTPase) that contains two SRC homology 2 (SH2) domains (Adachi et al., 1996; Matozaki and Kasuga, 1996; Neel and Tonks, 1997) . It binds directly to growth factor receptors, including the platelet-derived growth factor receptor, epidermal growth factor (EGF) receptor, c-KIT, and the erythropoietin receptor, in response to receptor stimulation with the corresponding ligand and undergoes tyrosine phosphorylation Vogel et al., 1993; Lechleider et al., 1993; Tauchi et al., 1994 Tauchi et al., , 1995 . In addition, although SHP-2 does not interact directly with the insulin receptor, it binds through its SH2 domains to tyrosine-phosphorylated docking proteins such as IRS1, IRS2, and GAB1 in response to insulin (KuhneÂ et al., 1993; Sun et al., 1995; Holgado-Madruga et al., 1996) . Thus, on ligand stimulation of various receptors, SHP-2 appears to be recruited either to the receptors themselves or to receptor docking proteins. A dominant negative mutant of SHP-2 inhibited activation of Ras and mitogen-activated protein (MAP) kinase, DNA synthesis, or cell proliferation induced by insulin, EGF, or lysophosphatidic acid (Noguchi et al., 1994; Milarski and Saltiel, 1994; Xiao et al., 1994; Bennett et al., 1996; Takeda et al., 1998) . Furthermore, microinjection of RNA encoding a dominant negative SHP-2 into Xenopus oocytes resulted in marked posterior truncation and inhibition of ®broblast growth factor-and activin-mediated mesoderm induction (Tang et al., 1995) . Disruption of the mouse Shp2 gene results in the failure of normal gastrulation and subsequent death in the early stages of embryogenesis, as well as in a marked impairment in ®broblast growth factorinduced activation of MAP kinase (Saxton et al., 1997) . Thus, SHP-2 appears to play important roles in intracellular signaling elicited by various growth factors and hormones, probably by contributing to activation of the Ras-MAP kinase pathway.
We have recently identi®ed a membrane glycoprotein, SHPS-1 Noguchi et al., 1996; Yamao et al., 1997) , also known as SIRP (Kharitonenkov et al., 1997) and BIT (Sano et al., 1997) , that possesses three immunoglobulin-like domains in its putative extracellular region as well as four YXX(L/V/I) motifs, which are potential tyrosine phosphorylation and SH2 domain binding sites, in its cytoplasmic region. Various mitogens, including serum, insulin, lysophosphatidic acid, and EGF, induce tyrosine phosphorylation of SHPS-1 and its subsequent association with SHP-2 in cultured cells Kharitonenkov et al., 1997; Ochi et al., 1997; Takeda et al., 1998) . Overexpression of SHPS-1 enhances insulin-induced activation of MAP kinase . Thus, SHPS-1 may contribute both to the recruitment of SHP-2 from the cytosol to a site near the plasma membrane and to its activation, thereby positively regulating the Ras-MAP kinase signaling cascade in response to insulin and other mitogens.
More recently, we and others have also shown that the engagement of integrins by components of the extracellular matrix (ECM), such as ®bronectin, induces tyrosine phosphorylation of SHPS-1 and its subsequent association with SHP-2 Oh et al., 1999) . Furthermore, the formation of the SHPS-1 ± SHP-2 complex appears to contribute to ®bronectin-induced activation of MAP kinase Oh et al., 1999) . These observations suggest that SHP-2 functions not only in growth factor-induced cell proliferation but also in processes related to integrin-mediated cell adhesion, spreading, and migration. Indeed, several lines of evidence have indicated that SHP-2 plays an active role in these integrin-mediated signaling events (Yu et al., 1998; Oh et al., 1999; Manes et al., 1999) . In addition, SHP-2 has been shown to mediate tyrosine dephosphorylation of focal adhesion kinase (FAK) and paxillin, both of which accumulate at focal adhesion contacts and are essential for integrin-mediated signaling (Yamauchi et al., 1995; Ouwens et al., 1996; Manes et al., 1999) . However, the precise role of SHP-2 in the integrinmediated signaling pathway is unclear. Moreover, the physiological signi®cance of SHP-2-mediated dephosphorylation events at focal adhesion contacts also remains to be determined.
The aim of the present study was to investigate whether, and if so how, SHP-2 contributes to integrin signaling with the use of a dominant negative mutant of the protein. Our results demonstrate speci®c roles for SHP-2 in cytoskeletal organization as well as in integrin-mediated cellular responses including cell attachment, spreading, and migration on ECM proteins.
Results

Eect of overexpression of a catalytically inactive SHP-2 on cytoskeletal organization
We have previously established Chinese hamster ovary cells expressing human insulin receptors (CHO-IR cells) and Rat-1 ®broblasts, both of which overexpress a catalytically inactive mutant of SHP-2 (SHP-2C/S) that acts in a dominant negative manner; these cells were designated CHO-SHP-2C/S and Rat-1-SHP-2C/S, respectively (Noguchi et al., 1994; Tsuda et al., 1998) . With the use of these cells, we have shown that SHP-2 mediates activation of Ras and MAP kinase in response to various mitogens and integrin-dependent cell adhesion (Noguchi et al., 1994; Takeda et al., 1998; Tsuda et al., 1998) . During the course of these studies, we noticed that, under normal culture conditions, Rat-1 cells exhibit an elongated, spindle-shaped morphology, with a high degree of polarity ( Figure 1A ). In contrast, Rat-1-SHP-2C/S cells show a¯attened, less polarized morphology ( Figure 1A) . A similar phenotype was apparent with all Rat-1-SHP-2C/S clones examined, although the extent of the dierences relative to the parental cells varied somewhat (data not shown). CHO-SHP-2C/S cells also appeared less polarized than did the parental CHO-IR cells ( Figure  1B) , suggesting that the eect of SHP-2C/S on cell shape is not restricted to Rat-1 cells. We did not detect marked morphological dierences between CHO-IR cells and CHO-SHP-2WT cells (data not shown), which overexpress wild-type SHP-2.
Cell shape and polarity are maintained by cellular components such as the actin-based cytoskeleton and focal adhesion contacts (Drubin and Nelson, 1996; Menzel, 1996) . We therefore examined whether these components are aected by the mutant SHP-2 in Rat-1 ®broblasts (these cells are more suitable for examination of cytoskeletal organization than are CHO cells). Immuno¯uorescence analysis with rhodamine-labeled phalloidin revealed that the number of actin stress ®bers that cross the cell body was markedly increased in Rat-1-SHP-2C/S cells compared with that in Rat-1 cells (Figure 2A,D) . The number of ®lopodium-like structures containing condensed polymerized actin at the cell periphery was also increased in Rat-1-SHP-2C/ S cells. The total amounts of actin in each cell line were similar as revealed by immunoblot analysis with antibodies to actin (data not shown). In cultured cells, tyrosine-phosphorylated proteins normally concentrate at focal adhesion contacts, where actin stress ®bers are connected with the ECM (Yamada and Miyamoto, 1995; Hanks and Polte, 1997) . Immunouorescence staining with a monoclonal antibody (mAb) to phosphotyrosine revealed that the amount of tyrosine-phosphorylated proteins in Rat-1-SHP-2C/ S cells was markedly greater than that in Rat-1 cells ( Figure 2B ,E). In addition, staining with a mAb to paxillin, which is a major component of the focal adhesion protein complex (Hanks and Polte, 1997) , showed that the amount of paxillin immunoreactivity was also markedly increased in Rat-1-SHP-2C/S cells ( Figure 2C,F) . These results suggest that inhibition of SHP-2 increases the formation of both actin stress ®bers and focal adhesion contacts.
Eects of overexpression of catalytically inactive SHP-2 on cell adhesion and phosphorylation of SHPS-1
Given that overexpression of SHP-2C/S increased the number of focal adhesion contacts in Rat-1 cells, we hypothesized that it would also increase the strength of cell-substratum adhesion. To investigate this hypothesis, we incubated con¯uent monolayers of Rat-1 or Rat-1-SHP-2C/S cells in Ca
2+
-and Mg
-free phosphate-buered saline (PBS) containing a low concentration of trypsin. Such treatment has been shown to reduce both cell-substratum adhesion and tyrosine phosphorylation of focal adhesion proteins (Maher, 1993) . Rat-1 cells detached from the culture dish in a time-dependent manner, with490% of the cells having detached by 20 min ( Figure 3A ). In contrast, 480% of Rat-1-SHP-2C/S cells remained attached to the culture dish after 30 min ( Figure 3A) . The same experiment performed with the CHO cell lines revealed that 490% of CHO-IR cells had detached from the dish after 30 min, whereas 560% of CHO-SHP-2C/S cells had detached at the same time point ( Figure 3B ). These -free PBS containing 0.005% trypsin. The numbers of cells that had detached from or that remained attached to the dish were counted, and the number of detached cells was expressed as a percentage of the total number of cells that were adherent before treatment. Data are means of triplicate determinations and are representative of three separate experiments results are consistent with the notion that inhibition of SHP-2 increases the strength of cell-substratum adhesion.
We next examined the eect of the same treatment on tyrosine phosphorylation of both paxillin and SHPS-1. Under basal conditions, the extent of tyrosine phosphorylation of SHPS-1 was markedly greater in Rat-1-SHP-2C/S cells or CHO-SHP-2C/S cells than in the corresponding parental cells ( Figure  4A ). The experimental treatment induced dephosphorylation of SHPS-1 in the parental cells. In contrast, tyrosine phosphorylation of SHPS-1 was unaected by the experimental treatment in either Rat-1-SHP-2C/S cells or CHO-SHP-2C/S cells ( Figure 4A ). These results suggest that inhibition of SHP-2 results in hyperphosphorylation of its substrate SHPS-1 and prevents SHPS-1 from undergoing dephosphorylation in response to the experimental treatment. In contrast to SHPS-1, the extent of tyrosine phosphorylation of paxillin in Rat-1-SHP-2C/S cells or CHO-SHP-2C/S cells under basal conditions did not dier substantially from that apparent in the corresponding parental cells ( Figure 4A ). Furthermore, exposure for 5 min to Ca 2+ -and Mg
-free PBS containing trypsin resulted in dephosphorylation of paxillin in Rat-1-SHP-2C/S and CHO-SHP-2C/S cells as well as in the corresponding parental cells ( Figure 4A ). These results suggest that paxillin might not be a direct substrate of SHP-2, and that the increase in the strength of cell adhesion induced by inhibition of SHP-2 correlates more closely with the increase in the extent of tyrosine phosphorylation of SHPS-1 than with the apparent lack of eect on the tyrosine phosphorylation of paxillin.
Eects of overexpression of catalytically inactive SHP-2 on integrin-mediated cell adhesion and spreading
We investigated whether overexpression of SHP-2C/S aects the ability of cells to adhere and spread when plated on culture dishes coated with ECM proteins. Rat-1-SHP-2C/S cells, CHO-SHP-2C/S cells, and the corresponding parental cells were detached from their culture dishes and then plated onto dishes coated with ®bronectin or vitronectin. The cells that had attached to the culture dishes were counted after incubation of the CHO and Rat-1 cell lines for 10 and 5 min, respectively; Rat-1 cells adhered rapidly to ®bronectin, with 490% of cells adhering after incubation for 10 min, as described previously (Clark et al., 1998) . The numbers of Rat-1-SHP-2C/S cells that adhered to the ®bronectin-or vitronectin-coated dishes after incubation for 5 min were 173+14% and 123+8% (means+s.e.mean, -free PBS containing 0.005% trypsin. Cell lysates were prepared and subjected to immunoprecipitation (IP) with mAb 2F34 to rat SHPS-1 or mAb 4C6 to hamster SHPS-1 (A), or with a mAb to paxillin (B), as indicated. Immunoprecipitates were then subjected to immunoblot analysis (IB) with HRP-conjugated mAb PY20 to phosphotyrosine (aPY), after which the same ®lters were reprobed with polyclonal antibodies to SHPS-1 (aSHPS-1) (A) or with the mAb to paxillin (B) to ensure that equal amounts of SHPS-1 or paxillin were present in each lane. The positions of SHPS-1, tyrosinephosphorylated SHPS-1 (SHPS-1-P), paxillin, and tyrosinephosphorylated paxillin (paxillin-P) are indicated Figure 5A ). In contrast, substantially fewer Rat-1-SHP-2C/S cells than Rat-1 cells adhered to dishes coated with the nonspeci®c substrate, bovine serum albumin (BSA) ( Figure 5A ). The numbers of CHO-SHP-2C/S cells that adhered to the ®bronectin-or vitronectincoated dishes were 150+5% and 191+6% (means+s.e.mean, n=5), respectively, of the corresponding values for CHO-IR cells ( Figure 5B ). Neither CHO cell line showed substantial adherence to BSAcoated dishes ( Figure 5B ). These results indicate that the initial rate of integrin-mediated cell attachment is increased as a result of inhibition of SHP-2. Rat-1 or Rat-1-SHP-2C/S cells were detached from culture dishes, replated onto ®bronectin-coated dishes, and allowed to adhere and spread. Cells were photographed after incubation for 5, 15, or 30 min, and the numbers of spread and unspread cells were counted. After 5 min, almost all Rat-1 cells showed a rounded shape, whereas as many as 30% of Rat-1-SHP-2C/S cells had begun to spread on the ®bronectin-coated dish ( Figure 6A,D) . After 15 min, 480% of Rat-1 cells still Figure 7 Eects of overexpression of catalytically inactive SHP-2 on cell adhesion-induced tyrosine phosphorylation of paxillin and p130Cas. Rat-1 and Rat-1-SHP-2C/S cells were detached from culture dishes, resuspended in serum-free DMEM, and then either maintained in suspension (susp) or replated onto culture dishes coated with ®bronectin (FN) (A) or FBS (serum) (B). After incubation for 30 min at 378C, cells were lysed and subjected to immunoprecipitation (IP) with a mAb to paxillin (apaxillin) or a mAb to p130Cas (aCas). Both types of immunoprecipitates were then subjected to immunoblot analysis (IB) with HRP-conjugated mAb PY20 to phosphotyrosine (aPY), after which the same ®lters were reprobed with the mAb to paxillin or polyclonal antibodies to p130Cas (aCas), as indicated, to ensure that equal amounts of paxillin or p130Cas were present in each lane. The positions of paxillin, tyrosine-phosphorylated paxillin (paxillin-P), p130Cas (Cas), and tyrosine-phosphorylated p130Cas (Cas-P) are indicated showed a rounded shape, whereas 470% of Rat-1-SHP-2C/S cells had begun to spread ( Figure 6B,E) . By 30 min, *50% of Rat-1 cells had begun to spread, although most of these cells had not formed membranous protrusions ( Figure 6C ); in contrast, 490% of Rat-1-SHP-2C/S cells had spread and displayed well-de®ned membranous protrusions at this time ( Figure 6F ). Thus, inhibition of SHP-2 appears to increase the rate of cell spreading on ®bronectin.
Eects of overexpression of catalytically inactive SHP-2 on adhesion-induced tyrosine phosphorylation of paxillin and p130Cas
Cell adhesion to the ECM increases tyrosine phosphorylation of paxillin (Schlaepfer and Hunter, 1996) and p130Cas (Nojima et al., 1995) . We therefore investigated the eects of SHP-2C/S on adhesion-induced tyrosine phosphorylation of these proteins. Consistent with the results of the previous studies, adhesion of Rat-1 cells to ®bronectin-coated dishes substantially increased the extent of tyrosine phosphorylation of both paxillin and p130Cas ( Figure 7A ). Adhesion of Rat-1-SHP-2C/S cells to ®bronectin resulted in more marked increases in tyrosine phosphorylation of paxillin and p130Cas than those apparent in Rat-1 cells ( Figure 7A ). Essentially identical results were obtained when both Rat-1 cell lines were allowed to adhere to culture dishes coated with fetal bovine serum (FBS) (Figure 7B ), the major ECM component of which is vitronectin. Thus, inhibition of SHP-2 appears to potentiate the increase in the extent of tyrosine phosphorylation of paxillin and p130Cas induced by cell adhesion. These observations are consistent with the stimulatory eect of the dominant negative mutant of SHP-2 on cell spreading, given that integrin-induced tyrosine phosphorylation of paxillin (Richardson et al., 1997) or p130Cas (Nakamura et al., 1998) correlates with cell spreading. Together, these results suggest that SHP-2 negatively regulates integrin-mediated early cellular responses to ECM components, including cell attachment, subsequent cell spreading, and tyrosine phosphorylation of paxillin and p130Cas.
Eects of overexpression of catalytically inactive SHP-2 on integrin-mediated and insulin-induced cell migration
Cell motility is controlled by a complex mechanism that includes adhesion to ECM proteins, reorganization of the actin-based cytoskeleton, and assembly of focal adhesion contacts (Lauenburger and Horwitz, 1996; Mitchison and Cramer, 1996; Waterman-Storer and Salmon, 1999) . Our observations that inhibition of SHP-2 aects these processes suggested that SHP-2 also might control cell motility. To test this hypothesis, we assayed the abilities of the various cell lines to migrate through a membrane coated with ®bronectin, vitronectin, or poly-L-lysine with the use of a Boyden chamber. A substantial number of CHO-IR cells migrated across the ®bronectin-coated membrane but not across the membrane coated with poly-L-lysine ( Figure 8A ). Because ®bronectin is a speci®c ligand for integrins (Schwartz et al., 1995) , these data suggest that migration of CHO-IR cells requires the engagement of integrins by ECM components. The rate of migration of CHO-SHP-2WT cells, which overexpress wild-type SHP-2, on ®bronectin was similar to that of CHO-IR cells ( Figure 8B ). In contrast, the migration rate of CHO-SHP-2C/S cells on ®bronectin was only 58+2% (mean+s.e.mean, n=5) of that of CHO-IR cells ( Figure 8B) . Similarly, the migration rates of Rat-1-SHP-2C/S cells on ®bronectin or vitronectin were only 57+1% and 73+0.5% (means+s.e.mean, n=5), respectively, of the corresponding values for Rat-1 cells ( Figure 8C ). Finally, overexpression of SHP-2C/S did not substantially aect the ability of insulin to stimulate the migration of CHO-IR cells on ®bronectin ( Figure 8D ). These results suggest that SHP-2 is important for cell migration mediated by the engagement of integrins by ECM proteins, but that it does not play a major role in the insulin signaling pathway that regulates cell motility.
Discussion
We have shown that inhibition of endogenous SHP-2 by overexpression of a catalytically inactive mutant markedly changed cell morphology by reducing polarity in two dierent cell lines, Rat-1 ®broblasts and CHO cells. Overexpression of this mutant SHP-2 also markedly increased the numbers of both actin stress ®bers and focal adhesion contacts, allowing cells to adhere more tightly to the culture dish. During the course of our study, cells derived from mice that express a mutant SHP-2 lacking the NH 2 -terminal SH2 domain were also shown to exhibit an increased number of focal contacts and aggregation of condensed ®lamentous (F)-actin (Yu et al., 1998) . One possible mechanism whereby SHP-2 might control the formation of focal adhesion contacts is that SHP-2 may directly regulate the remodeling of focal adhesion contacts by mediating the dephosphorylation of tyrosine-phosphorylated substrates at such sites. Inhibition of SHP-2 thus might prevent the disassembly of preformed focal adhesion contacts, and thereby promote their accumulation.
Cell adhesion to the ECM maintains tyrosine phosphorylation of paxillin, FAK, and p130Cas, all of which localize at focal adhesion contacts (Yamada and Miyamoto, 1995; Nojima et al., 1995; Schlaepfer and Hunter, 1996; Hanks and Polte, 1997) . The extent of tyrosine phosphorylation of paxillin in adherent cells was not substantially increased by overexpression of SHP-2C/S. Tyrosine phosphorylation of FAK and p130Cas was also unaected by inhibition of SHP-2 in such cells (data not shown). In contrast, the extent of tyrosine phosphorylation of SHPS-1 was greatly increased in cells overexpressing the mutant SHP-2. Furthermore, whereas paxillin was dephosphorylated in response to exposure of cells overexpressing the SHP-2 mutant to Ca 2+ -and Mg
2+
-free PBS and trypsin, SHPS-1 was not. These results indicate that SHPS-1 is a direct substrate of SHP-2. In addition, paxillin, p130Cas, and FAK do not appear to be direct substrates of SHP-2, suggesting that other PTPases mediate the tyrosine dephosphorylation of these proteins at focal adhesion contacts during cell detachment.
We have also shown that overexpression of SHP-2C/S markedly enhanced integrin-mediated cell adhesion and spreading on ECM proteins as well as the Roles of SHP-2 in integrin-mediated signaling K Inagaki et al associated tyrosine phosphorylation of paxillin and p130Cas. In contrast, Yu et al. (1998) showed that ®broblasts from Shp2 knockout mice exhibited a reduced rate of spreading and unchanged adhesiveness on ®bronectin. In addition, Oh et al. (1999) showed that the extents of the adhesion-induced increases in tyrosine phosphorylation of paxillin and p130Cas were reduced in Shp2 7/7 mutant ®broblasts. These apparent discrepancies between our results and those of Yu et al. (1998) and Oh et al. (1999) may be attributable, at least in part, to the dierences in the manner of SHP-2 inhibition; whereas we adopted a dominant negative approach, they adopted a loss-offunction approach in studying the eects of an SHP-2 mutant that lacks the NH 2 -terminal SH2 domain. However, the enhancement of adhesion-induced tyrosine phosphorylation of paxillin and p130Cas apparent in Rat-1-SHP-2C/S cells, as compared with parental Rat-1 cells, is consistent with the enhanced adhesion and spreading of these cells on ECM components.
The mechanism by which SHP-2 might negatively regulate integrin-mediated cell adhesion signals remains unclear. The integrin-mediated formation of focal adhesion contacts and tyrosine phosphorylation of paxillin are dependent on Rho activity (Barry et al., 1997; Clark et al., 1998) . Furthermore, tyrosine kinase activity is required for upstream elements to activate Rho (Nobes et al., 1995) . It is therefore possible that SHP-2 inhibits the activation of Rho by dephosphorylating an unidenti®ed protein. Integrinmediated adhesion and spreading of macrophages from viable motheaten (me v ) mutant mice are also enhanced (Roach et al., 1998) . The gene encoding SHP-1, another SH2 domain-containing PTPase, is mutated in me v mice, resulting in a loss of SHP-1 enzymatic activity (Tsui et al., 1993) . In addition, phosphoinositide 3-kinase activity is required for the enhanced cell attachment of macrophages from these mice (Roach et al., 1998) . Thus, it is also possible that SHP-2 regulates integrin-dependent cell adhesion by controlling phosphoinositide 3-kinase activity. Another possibility is that SHP-2 regulates integrin function more directly. This notion may come from our recent observation showing that ®bronectin-induced activation of MAP kinase, and possibly that of Ras, is inhibited by a dominant negative mutant of SHP-2 . Ras has been proposed to play a role in regulating the turnover of focal adhesion contacts; dominant negative Ras stimulates focal adhesion formation (Clark and Hynes, 1996; Schlaepfer and Hunter, 1998) . Furthermore, Ras-Raf-MAP kinase activation inhibits integrin function (Hughes et al., 1997) . Together, these observations suggest that a dominant negative SHP-2 is likely to impair activation of Ras and MAP kinase during cell adhesion to the ECM, which, in turn, might enhance integrin-mediated cell adhesion, cell spreading, and tyrosine phosphorylation of p130Cas and paxillin.
In contrast to the stimulatory eects of SHP-2C/S on cell adhesion and spreading, this mutant markedly inhibited integrin-mediated cell migration, suggesting that SHP-2 may positively regulate cell motility on the ECM. Regulation of cell-substratum adhesion through the formation and breakdown of focal adhesion contacts is required for cell migration (Schwarzbauer, 1997) . Therefore, the inhibitory eect of SHP-2C/S on cell migration might result from its ability to increase the formation of focal adhesion contacts and to strengthen cell adhesion to the ECM. Thus, SHP-2 may function as a temporal regulator that limits the number of focal adhesion contacts and the strength of cell adhesion, thereby allowing cells to adopt an adhesion state permissive for migration. Alternatively, the impaired motility of cells overexpressing SHP-2C/S might result from the marked inhibition of adhesioninduced activation of MAP kinase in these cells , given that Ras and MAP kinase appear to be required for cell migration on the ECM (AnandApte et al., 1997; Klemke et al., 1997) . SHP-2 was recently shown to be required for cell migration induced by insulin-like growth factor-1 or by plateletderived growth factor (Manes et al., 1999; Qi et al., 1999) . However, insulin-induced cell migration was not substantially aected by SHP-2C/S under our assay conditions, suggesting that SHP-2 might not be required for this eect of insulin. Thus, the relative Both reduced cell motility and enhanced formation of focal adhesion contacts are characteristics of cells derived from Fak knockout mice (Ilic et al., 1995) . In addition, the phenotype of Fak knockout mice resembles that of Shp2 knockout mice, with both types of animal showing embryonic death and general mesodermal defects (Ilic et al., 1995; Saxton et al., 1997) . We have recently shown that ®bronectin-induced tyrosine phosphorylation of SHPS-1 and its association with SHP-2 are markedly decreased in cells from Fak 7/7 mice . The reduced extent of tyrosine phosphorylation of SHPS-1 in these cells might impair the function of SHP-2 by inhibiting either the recruitment of SHP-2 to a site near the plasma membrane or the stimulation of its PTPase activity , possibly explaining the similarities in phenotype between the Fak and Shp2 knockout animals as well as those between FAKde®cient cells and cells expressing a dominant negative SHP-2.
In summary, our data indicate that SHP-2 regulates the formation of actin stress ®bers and focal adhesion contacts, thereby contributing to maintenance of cell shape. Furthermore, SHP-2 appears to regulate integrin-mediated processes including cell adhesion, cell spreading, and cell migration. Further studies are required to elucidate the precise molecular mechanisms by which SHP-2 achieves these eects.
Materials and methods
Cells and antibodies
CHO-IR cells and CHO-IR cells that overexpress either wildtype SHP-2 (CHO-SHP-2WT cells) or a catalytically inactive SHP-2 (CHO-SHP-2C/S cells) (Noguchi et al., 1994) were maintained in Ham's F-12 medium supplemented with 10% FBS. Rat-1 ®broblasts and Rat-1 cells that overexpress catalytically inactive SHP-2 (Rat-1-SHP-2C/S cells) were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% FBS. Rabbit polyclonal antibodies to SHPS-1 were generated in response to a glutathione S-transferase fusion protein containing the COOH-terminal region of rat SHPS-1. The mAb 4C6 to hamster SHPS-1 and mAb 2F34 to rat SHPS-1 were prepared as described Takada et al., 1998) . A mAb to paxillin and a mAb to p130Cas were obtained from Transduction Laboratories; horseradish peroxidase (HRP)-conjugated mAb PY20 to phosphotyrosine and polyclonal antibodies to p130Cas were from Santa Cruz Biotechnology;¯uorescein isothiocyanate (FITC)-conjugated mAb PY20 was from Calbiochem; FITCconjugated sheep antibodies to mouse immunoglobulin were from Amersham Pharmacia Biotech; polyclonal antibodies to actin and rhodamine-labeled phalloidin were from Sigma.
Examination of cell morphology
Rat-1-SHP-2C/S cells, CHO-SHP-2C/S cells, or the corresponding parental cells were seeded into fresh medium containing 10% FBS at a density of 1610 5 cells/ml. The cells were then incubated for 48 h at 378C in polystyrene culture dishes (6 cm) placed in a humidi®ed incubator containing 5% CO 2 . Cells were then viewed under a light microscope equipped with phase-contrast optics (model IX 70; Olympus), and at least ®ve ®elds were photographed at a total magni®cation of 2006.
Cell adhesion assay
Polystyrene culture dishes (10 cm) were coated with ®bronectin (10 mg/ml) (Sigma) or vitronectin (10 mg/ml) (Sigma) diluted in PBS or with FBS by incubation either overnight at 48C or for 2 h at 378C, and were subsequently air-dried. Nonspeci®c binding sites were blocked by incubation for 1 h at 378C with a solution of BSA (100 mg/ ml) in PBS. Cells cultured in dishes until they had achieved a con¯uent monolayer were detached by exposure to 0.025% trypsin, collected by centrifugation, and washed once with serum-free medium. They were then replated at a density of 1610 5 cells/ml on culture dishes coated with ECM proteins, and incubated for 5 or 10 min at 378C in serum-free medium and under a humidi®ed atmosphere containing 5% CO 2 . After washing the cells twice with PBS, the number of cells that had attached to each dish was counted microscopically in at least ®ve ®elds and at a total magni®cation of 2006. For determination of the strength of adhesion, con¯uent monolayers of cells were washed twice with PBS and then incubated for 0 ± 30 min at 378C in Ca 2+ -and Mg
2+
-free PBS containing 0.005% trypsin. The numbers of cells that had detached from or remained attached to each dish were counted.
Analysis of cell spreading
Rat-1 or Rat-1-SHP-2C/S cells were detached from culture dishes and replated on ®bronectin-coated dishes (6 cm), prepared as described above, at a density of 1610 5 cells/ml. The cells were then incubated at 378C in serum-free DMEM under a humidi®ed atmosphere containing 5% CO 2 . Cells were viewed under a phase-contrast microscope, and random ®elds were photographed after 5, 15 and 30 min at a total magni®cation of 2006. Cells that had not spread were de®ned as phase-bright and rounded, whereas spread cells were not phase-bright, exhibited extensive membranous protrusions, and lacked a rounded morphology. The numbers of spread and unspread cells were counted in at least ®ve ®elds.
Cell migration assay
Migration of CHO or Rat-1 cells was assessed with a Boyden chamber assay essentially as described previously (Horikawa et al., 1995) . Polyvinylpyrrolidine-free ®lters with a pore size of 8 mm (Neuroprobe) were coated for 30 min with ®bronectin (10 mg/ml), vitronectin (10 mg/ml), or poly-Llysine (10 mg/ml) (Sigma) in serum-free culture medium. The coated ®lters were then dried and placed over the lower well of a Boyden multiwell chemotactic chamber that had been ®lled with serum-free medium either supplemented or not with 10 nM insulin. The gasket and upper part of the chamber were then assembled. After detachment from the culture dish by exposure to trypsin, 1.5610 5 cells in 0.2 ml of serum-free medium were added to the upper well. The chamber was then placed in a humidi®ed incubator containing 5% CO 2 , and the cells were incubated for 3 h at 378C. Cells that had migrated through the ®lter were ®xed in methanol, washed with PBS, and exposed to Giemsa stain (Nakarai Tesque) for 15 s. After three washes in water, the ®lter was mounted on a glass slide. The side of the ®lter to which the cells had been added was scraped. The number of migrated cells was counted in at least ®ve ®elds at a total magni®cation of 2006 under a microscope ®tted with a grid eyepiece.
Immunoprecipitation and immunoblot analysis
After aspiration of culture medium, cells were immediately washed with ice-cold PBS and then frozen in liquid nitrogen. The cells were thawed on ice in 1 ml of ice-cold lysis buer (20 mM Tris-HCl (pH 7.6), 140 mM NaCl, 1 mM EDTA, 1% (v/v) Nonidet P-40) containing 5 mM NaF, 1 mM phenylmethylsulfonyl¯uoride, aprotinin (10 mg/ml), and 1 mM sodium vanadate. The cell lysates were centrifuged at 10 000 g for 15 min at 48C, and the resulting supernatants were subjected to immunoprecipitation and immunoblot analysis. For immunoprecipitation, the supernatants were incubated for 3 h at 48C with various antibodies bound to protein G-Sepharose beads (20 ml of beads) (Amersham Pharmacia Biotech). The beads were then washed three times with 1 ml of WG buer (50 mM HEPES-NaOH (pH 7.6), 150 mM NaCl, 0.1% (v/v) Triton X-100) suspended in SDS sample buer, and boiled for 5 min. Gel electrophoresis and immunoblot analysis with various antibodies and the ECL detection system (Amersham Pharmacia Biotech) were performed as described previously (Noguchi et al., 1994) .
Immunocytochemistry
Rat-1 or Rat-1-SHP-2C/S cells were seeded on glass cover slips in a six-well plate and cultured in DMEM supplemented with 10% FBS. After washing twice with PBS, cells were ®xed with ice-cold acetone for 2 min and then incubated for 2 h at room temperature in TBS-T (20 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.05% (v/v) Tween-20) containing 5% (w/v) nonfat dried milk and 3% (w/v) BSA. They were then incubated for 1 h with FITC-conjugated mAb PY20 to phosphotyrosine (1 : 100 dilution in PBS containing 1% BSA) or with a mAb to paxillin (1 : 50 dilution in PBS containing 1% BSA). Rhodamine-labeled phalloidin (1 : 250 dilution in PBS containing 1% BSA) was then added to stain F-actin, and cells were incubated for an additional 30 min. For paxillin staining, cells were then washed twice with PBS and incubated for 30 min with FITC-conjugated sheep antibodies to mouse immunoglobulin (1 : 50 dilution in PBS containing 1% BSA). After washing three times with PBS, cells were analysed with a laser-scanning confocal microscope imaging system (model MRC-1024; Bio-Rad) and built-up images were constructed.
